Table 1 illustrates the association of L3MBTL3 expression with the clinical characteristics of GC patients. L3MTBL3 overexpression was linked to a higher T stage (p = 0.009), N stage (p = 0.002), and histologic grade (p = 0.025) compared with low expression. There was no significant relationship between L3MBTL3 expression and any other clinicopathologic variables. As for the IHC cohort, the overexpression of L3MBTL3 was linked to advanced T stage (p = 0.035), N stage (p = 0.007), and clinical stage (p = 0.032) compared with low expression (Table 2). The gene discussed is L3MBTL3; the disease is gastric cancer.